Abiopharma

🔍 Stiefel Jennifer D H (Director)

Company: IP STRATEGY HOLDINGS, INC. (IPST)

Report Date: 2026-08-02

Detailed Transactions and Holdings:

• Acquired 209 shares of Common Stock (Direct)
  Date: 2026-08-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,466.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 62 shares of Common Stock at $2.16 per share (Direct)
  Date: 2026-08-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,404.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Acquired 1,459 shares of Common Stock (Direct)
  Date: 2026-08-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,342.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 433 shares of Common Stock at $2.16 per share (Direct)
  Date: 2026-08-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,909.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4
• Sold 209 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 416.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5
• Sold 1,459 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,916.00 | transaction_form_type: 4 | Footnotes: F1, F5, F5, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock.
• F2: The reporting person relinquished the shares of Common Stock reported herein and the issuer cancelled such shares and returned them to issuer's treasury in exchange for remitting certain tax withholding obligations of the reporting person resulting from the vesting of the RSUs. As such, no shares of the issuer were sold by the reporting person.
• F3: Represents the per share closing price of the issuer's Common Stock on the applicable vesting date or, if there was no closing price on such date, the closing price on the trading date that was immediately prior to such vesting date.
• F4: These securities are held by Justin B. Stiefel, the spouse of the reporting person. For purposes of Section 16 of the Exchange Act, the reporting person disclaims beneficial ownership of any such securities, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
• F5: The RSUs vest over an eighteen (18) month period beginning September 1, 2025, with six (6) months of service-based vesting deemed satisfied as of February 2, 2026, and the remaining units vesting in equal installments May 2, 2026, August 2, 2026, November 2, 2026, and February 2, 2027, subject to continued service.